Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York


New York State Attorney General, Letitia James, speaks during a news conference, to announce criminal justice reform in New York City, U.S., May 21, 2021.
Brendan McDermid | Reuters

New York Attorney General Letitia James announced on Saturday that Johnson & Johnson has agreed to halt sales of opioids nationwide in a $230 million settlement with New York state.

As part of the settlement, the company will resolve opioids-related claims and allocate payments over nine years. It could also pay $30 million more in the first year if the state executive chamber signs into law new legislation creating an opioid settlement fund, according to the press release from James’ office.

“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James said in a statement.

“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country,” she said.

This is breaking news. Please check back for updates.

Articles You May Like

Read Warren Buffett’s 2024 annual letter to shareholders
Economic confidence among small business owners hits highest level since Biden took office
A ‘family vacation’ for two: Why more parents are taking trips with one child at a time
Chinese tourists are driving Asia-Pacific’s travel boom — flight bookings to hit pre-pandemic levels
Germany’s housebuilding sector is in a ‘confidence crisis’ as the economy struggles